Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 3Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Waldenstrom Macroglobulinemia 1Pancreatic Neoplasms 1Neurofibrosarcoma 1Neurofibromatosis 1 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Adenocarcinoma, Follicular 1

Interventions

Doxorubicin 11Ifosfamide 9Radiotherapy 6Filgrastim 4pegfilgrastim 3Sorafenib 2Sirolimus 2Magnetic Resonance Spectroscopy 2Imatinib Mesylate 2Etoposide 2Chemotherapy, Adjuvant 2temsirolimus 1selinexor 1romidepsin 1ribociclib 1perifosine 1pazopanib 1lorvotuzumab mertansine 1liposomal doxorubicin 1indolepropanol phosphate 1exatecan 1cixutumumab 1brostallicin 1X-Rays 1Watchful Waiting 1Trabectedin 1Sunitinib 1Specimen Handling 1STA 9090 1Razoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neurofibrosarcoma × Photons × Clear all
NCT02700230 2024-09-27

Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery

Mayo Clinic

Phase 1 Completed
9 enrolled
CNSSarcoma

Neurofibromatosis 1, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡